Ads

Gleacher & Company Welcomes Another Addition to Equity Healthcare Team

Gleacher & Company Securities, Inc., a broker-dealer subsidiary of
Gleacher & Company, Inc. (Nasdaq: GLCH), today announced another
addition to its Healthcare Research team with the hiring of Ying Huang.
“I
continue to believe that expanding our equity platform is a critical
element in our overall growth initiative. Adding Ying to our existing
Healthcare Team is a meaningful step toward capitalizing on the
opportunities that we see in Healthcare.”
Mr. Huang joins Gleacher & Company from Credit Suisse where he covered
Biotechnology companies across all market capitalizations. Prior to
working on Wall Street, Mr. Huang spent 10 years at the Schering-Plough
Research Institute where he was a Principal Scientist in the drug
discovery and development area. He received his PhD in Bio-Organic
Chemistry from Columbia University and completed his undergraduate work
at the University of Science and Technology of China.
Robert Meier, Head of Gleacher & Companys Equity division, said, We
are thrilled to have Ying join our team. Adding a biotech analyst with
such deep scientific knowledge will enhance our product offering to our
clients. We are committed to establishing a strong Healthcare research
vertical and our well respected team of Amit Hazan, Joe France, Sung Ji
Nam, and now Ying Huang will form the nucleus of Gleacher Healthcare.
Eric Gleacher, Chief Executive Officer of Gleacher & Company, said, I
continue to believe that expanding our equity platform is a critical
element in our overall growth initiative. Adding Ying to our existing
Healthcare Team is a meaningful step toward capitalizing on the
opportunities that we see in Healthcare.
About Gleacher & Company
Gleacher & Company, Inc. (Nasdaq: GLCH) is an independent, full service
investment bank that provides corporate and institutional clients with
strategic, research-based investment opportunities, capital raising, and
financial advisory services, including merger and acquisition,
restructuring, recapitalization, and strategic alternative analysis, as
well as securities brokerage services. For more information, please
visit www.gleacher.com.
Forward Looking Statements
This press release contains forward-looking statements. These
statements are not historical facts but instead represent the Companys
belief regarding future events, many of which, by their nature, are
inherently uncertain and outside of the Companys control. The Companys
forward-looking statements are subject to various risks and
uncertainties, including the conditions of the securities markets,
generally, and acceptance of the Companys services within those markets
and other risks and factors identified from time to time in the
Companys filings with the Securities and Exchange Commission. It is
possible that the Companys actual results and financial condition may
differ, possibly materially, from the anticipated results and financial
condition indicated in its forward-looking statements. You are cautioned
not to place undue reliance on these forward-looking statements. The
Company does not undertake to update any of its forward-looking
statements.

Source: Business Wire